Maturity-onset diabetes of the young (MODY) is a model for genetic studies of non-insulin-dependent diabetes mellitus. We have identified 15 MODY families in which diabetes is not the result of mutations in the glucokinase gene. This cohort of families will be useful for identifying other diabetes-susceptibility genes. Nine other candidate genes potentially implicated in insulin secretion or insulin action have been tested for linkage with MODY in these families, including glucokinase regulatory protein, hexokinase II, insulin receptor substrate 1, fatty acid–binding protein 2, glucagon-like peptide-1 receptor, apolipoprotein C-II, glycogen synthase, adenosine deaminase (a marker for the MODY gene on chromosome 20), and phosphoenolpyruvate carboxykinase. None of these loci showed evidence for linkage with MODY, implying that mutations in these genes do not make a major genetic contribution to the development of MODY. In addition to these linkage analyses, one or two affected subjects from each family were screened for the presence of the A to G mutation at nucleotide 3,243 of the mitochondrial tRNALeu(UUR) gene. This mutation was not found in any of these subjects. Finally, we report the localization of the gene encoding the regulatory protein of glucokinase to chromosome 2, band p22.3 and the identification of a restriction fragment length polymorphism at this locus.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1994
Search for a Third Susceptibility Gene for Maturity-Onset Diabetes of the Young: Studies With Eleven Candidate Genes
Martine Vaxillaire;
Martine Vaxillaire
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Nathalie Vionnet;
Nathalie Vionnet
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Corinne Vigouroux;
Corinne Vigouroux
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Fang Sun;
Fang Sun
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Rafael Espinosa, III;
Rafael Espinosa, III
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Michelle M Lebeau;
Michelle M Lebeau
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Markus Stoffel;
Markus Stoffel
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Markku Lehto;
Markku Lehto
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Jacques S Beckmann;
Jacques S Beckmann
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Michel Detheux;
Michel Detheux
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Philippe Passa;
Philippe Passa
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Daniel Cohen;
Daniel Cohen
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Emile Van Schaftingen;
Emile Van Schaftingen
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Gilberto Velho;
Gilberto Velho
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Graeme I Bell;
Graeme I Bell
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Philippe Froguel
Philippe Froguel
Human Polymorphism Study Center, the Endocrinology Department, Saint-Louis Hospital, and INSERM U358
Paris, France
Department of Biochemistry and Fourth Department of Medicine, Helsinki University
Helsinki, Finland
Laboratory of Physiological Chemistry, International Institute of Cellular and Molecular Pathology, and Universite Catholique de Louvain
Brussels, Belgium
Howard Hughes Medical Institute, the Departments of Biochemistry, Molecular Biology, and Medicine, the University of Chicago
Chicago, Illinois
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Philippe Froguel, Centre d'Etude du Polymorphisme Humain (CEPH), 27 rue Juliette Dodu, 75010 Paris, France.
Diabetes 1994;43(3):389–395
Article history
Received:
September 07 1993
Revision Received:
November 11 1993
Accepted:
November 11 1993
PubMed:
7508874
Citation
Martine Vaxillaire, Nathalie Vionnet, Corinne Vigouroux, Fang Sun, Rafael Espinosa, Michelle M Lebeau, Markus Stoffel, Markku Lehto, Jacques S Beckmann, Michel Detheux, Philippe Passa, Daniel Cohen, Emile Van Schaftingen, Gilberto Velho, Graeme I Bell, Philippe Froguel; Search for a Third Susceptibility Gene for Maturity-Onset Diabetes of the Young: Studies With Eleven Candidate Genes. Diabetes 1 March 1994; 43 (3): 389–395. https://doi.org/10.2337/diab.43.3.389
Download citation file:
59
Views